Stock ScreenerStock IdeasFounder-Led CompaniesFounder-Led CompaniesA Bain & Co. study found that founder-led companies performed "3.1 times better" during the study period of 1999 to 2014
Stock ScreenerStock IdeasFounder-Led Companies
Ticker: AIV + 109 more
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.28B | $169.16 | $213.27 | 26.08% | Strong Buy | 11 | 8.95% | N/A | 47.05% | 16.40% | |||
| AIV | APARTMENT INVESTMENT & MANAGEMENT CO | $854.37M | $5.93 | $10.00 | 68.63% | Buy | 1 | N/A | N/A | N/A | N/A | |||
| LPSN | LIVEPERSON INC | $36.16M | $3.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -17.14% | |||
| MPW | MEDICAL PROPERTIES TRUST INC | $3.13B | $5.20 | $5.00 | -3.85% | Strong Sell | 1 | 5.24% | N/A | N/A | N/A | |||
| ARE | ALEXANDRIA REAL ESTATE EQUITIES INC | $10.10B | $58.45 | $58.33 | -0.20% | Hold | 9 | -3.55% | N/A | N/A | N/A | |||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $2.19B | $22.75 | $70.25 | 208.79% | Strong Buy | 12 | 35.50% | N/A | 24,047.89% | 43.61% | |||
| HR | HEALTHCARE REALTY TRUST INC | $6.06B | $17.23 | $20.00 | 16.08% | Buy | 6 | 0.38% | N/A | N/A | N/A | |||
| VSAT | VIASAT INC | $5.77B | $42.64 | $39.33 | -7.76% | Hold | 3 | 3.74% | N/A | -3.32% | -1.02% | |||
| W | WAYFAIR INC | $14.39B | $110.39 | $115.78 | 4.89% | Strong Buy | 23 | 7.01% | N/A | -28.28% | 25.12% | |||
| BYND | BEYOND MEAT INC | $424.54M | $0.94 | $1.70 | 81.62% | Strong Sell | 4 | -1.09% | N/A | N/A | -13.12% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.